Bionano Genomics Inc (BNGO)
0.2824
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.285
0.00 (0.00%)
After-Hours: 20:00
Bionano Genomics Max Drawdown (5Y): 99.81% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.81% |
| September 30, 2024 | 99.75% |
| August 31, 2024 | 99.75% |
| July 31, 2024 | 99.65% |
| June 30, 2024 | 99.59% |
| May 31, 2024 | 99.52% |
| April 30, 2024 | 99.52% |
| March 31, 2024 | 99.35% |
| February 29, 2024 | 99.30% |
| January 31, 2024 | 99.24% |
| December 31, 2023 | 99.19% |
| November 30, 2023 | 99.19% |
| October 31, 2023 | 99.19% |
| September 30, 2023 | 98.18% |
| August 31, 2023 | 98.09% |
| July 31, 2023 | 96.85% |
| June 30, 2023 | 96.85% |
| May 31, 2023 | 96.85% |
| April 30, 2023 | 96.85% |
| March 31, 2023 | 96.85% |
| February 28, 2023 | 96.85% |
| January 31, 2023 | 96.85% |
| December 31, 2022 | 96.85% |
| November 30, 2022 | 96.85% |
| October 31, 2022 | 96.85% |
| Date | Value |
|---|---|
| September 30, 2022 | 96.85% |
| August 31, 2022 | 96.85% |
| July 31, 2022 | 96.85% |
| June 30, 2022 | 96.85% |
| May 31, 2022 | 96.85% |
| April 30, 2022 | 96.85% |
| March 31, 2022 | 96.85% |
| February 28, 2022 | 96.85% |
| January 31, 2022 | 96.85% |
| December 31, 2021 | 96.85% |
| November 30, 2021 | 96.85% |
| October 31, 2021 | 96.85% |
| September 30, 2021 | 96.85% |
| August 31, 2021 | 96.85% |
| July 31, 2021 | 96.85% |
| June 30, 2021 | 96.85% |
| May 31, 2021 | 96.85% |
| April 30, 2021 | 96.85% |
| March 31, 2021 | 96.85% |
| February 28, 2021 | 96.85% |
| January 31, 2021 | 96.85% |
| December 31, 2020 | 96.85% |
| November 30, 2020 | 96.85% |
| October 31, 2020 | 96.85% |
| September 30, 2020 | 96.85% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
93.69%
Minimum
Nov 2019
99.81%
Maximum
Oct 2024
97.22%
Average
96.85%
Median
Apr 2020
Max Drawdown (5Y) Benchmarks
| Revvity Inc | 59.01% |
| Bruker Corp | 46.31% |
| Azenta Inc | 70.61% |
| Harvard Bioscience Inc | 78.65% |
| Akoya Biosciences Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -81.34 |
| Beta (5Y) | 2.371 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 570.5% |
| Historical Sharpe Ratio (5Y) | -0.0889 |
| Historical Sortino (5Y) | -1.062 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.10% |